Read all about it! The latest news from the medical technology experts

Ingeneus launches IOPvet device

Further patents issued in key regions for the eyePressure device

Revolutionising high eyePressure detection around Australia - and even in the Antarctic

Patents issued in key regions for the eyeTelehealth Platform

Patent issued for Ingeneus' eyeConnect device in China

Patents issued in the US and China for eyeTelehealth products

World first eyeConnect unveiled at Frankston Hospital

Ingeneus products - Good Design Awards winners

Ingeneus products in Good Design Awards finals

Ingeneus appoints new GM Manufacturing

Ingeneus launches eyePressure device

Ingeneus works with SMART Arm

Ingeneus achieves CE Marking for ophthalmic system

Ingeneus on the move

Ingeneus develops new remote diagnostic tool

Ingeneus wins TGA and CE manufacturing approval for cataract surgery device

Medical device treats Ocular Pathologies during Vitreoretinal Surgery

V-Patch Medical Systems: reaching the hearts of the travelling public

Double Success for Ingeneus in Government Program

Ingeneus advocates change to the Therapeutic Goods Administration (TGA)

Ingeneus Exhibits at AusMedtech 2011 Conference

Dynamic enhancement of Ingeneus QMS for medical devices and biomedical applications

Exciting opportunities at BiOS 2011 for Ingeneus

Ingeneus engages with emerging markets

New branding & website under Design Vic Business Immersion program

Ingeneus completes software training with its clients

Ingeneus passes TGA Surveillance Audit

Ingeneus signs licensing agreement for low cost diabetic retinopathy system

Ingeneus launches eyePressure device

News

Further patents issued in key regions for the eyePressure device

Ingeneus CEO, Richard Walmsley is pleased to announce that Patents have now been issued in France, Germany, Italy, Spain, the United Kingdom, and Indonesia for the eyePressure device. The eyePressure is one of the key elements of the innovative eyeTelehealth platform.

1 - Further patents issued in key regions for the eyePressure device“The issuing of these Patents is great acknowledgement that the eyePressure device is novel, new technology. It is the first of its kind not only in Australia, the US, China and Vietnam, but also in several European countries, the United Kingdom, and Indonesia,” Mr Walmsley said.

“Having these patents lends greater credibility to our product in these important markets,” he said.

The eyePressure, a disposable eye pressure assessment device targeted for use by primary healthcare practitioners, is one of the elements of the eyeTelehealth platform. This platform and device is making eye care easy in primary health, while extending the reach of the specialist through ophthalmic telemedicine.

“High eye pressure can be an indication of serious eye diseases such as Glaucoma, a leading cause of blindness. Early detection is crucial,” Ingeneus CEO, Richard Walmsley said. “Hence the need for the eyePressure – making early detection simple for primary healthcare practitioners.”

The other elements of this innovative platform include:

  • eyeConnect – a remote telehealth assessment system that collects information including: patient history, acuity test results, intra-ocular pressure assessment and high-resolution photographs
  • eyeTelecloud – a secure cloud environment that allows authorised personnel to access, view, and report on patient data from eyeConnect systems.

 

For more information, please email enquiries@ingeneus.com.au or call +61 3 9558 6334. Alternatively, visit www.eyepressure.net.au and www.eyeconnect.net.au for further details on these game-changing medical devices.

24 March 2021